Spread of the FAR-MRSA clone, a fusidic acid- and meticillin-resistant Staphylococcus aureus ST121, Europe, 2014 to 2024.

Louise Roer, Nicolas Yin, Olivier Denis, Karuna Ew Vendrik, Romy D Zwittink, Daan W Notermans, Monique Perrin, Kirstin Khonyongwa, Anne Tristan, Benjamin Youenou, Franziska Layer-Nicolaou, Guido Werner, Hege Enger, Emily Charlotte Henry Eikrem, Jessica Darenberg, Barbro Mäkitalo, Magnus Paulsson, Jonas Björkman, Hong Fang, Erika Tång HallbäckMartin Sundqvist, Laura Lindholm, Kartyk Moganeradj, Silvia García-Cobos, Javier E Cañada-García, Barbara Juliane Holzknecht, Helle Brander Eriksen, Morten Hoppe, Mette Damkjær Bartels, Jose Alfredo Samaniego Castruita, Tinna Ravnholt Urth, Anders Rhod Larsen, Andreas Petersen

Forskningsoutput: TidskriftsbidragLetterPeer review

Sammanfattning

We describe the genetic characteristics of a fusidic acid- and meticillin-resistant Staphylococcus aureus (MRSA) clone widespread in Europe, based on whole genome sequences from 317 isolates. The clone is causing impetigo and other skin and soft tissue infections, primarily in young children. Comparison with publicly available S. aureus ST121 sequences showed that the clone is clearly distinct from previously described ST121 clones. European and other international readers should be aware of the emergence of this community-acquired MRSA clone.

Ämnesklassifikation (UKÄ)

  • Mikrobiologi inom det medicinska området

Fingeravtryck

Utforska forskningsämnen för ”Spread of the FAR-MRSA clone, a fusidic acid- and meticillin-resistant Staphylococcus aureus ST121, Europe, 2014 to 2024.”. Tillsammans bildar de ett unikt fingeravtryck.

Citera det här